PROCARDIA
Pronunciation: nye-FED-i-peen

What it isL-type calcium-channel-blocking vasodilator; hypertension, angina, Raynaud phenomenon, and off-label tocolysis.
Why this oneExtended-release nifedipine is a preferred oral antihypertensive in pregnancy and also treats Raynaud vasospasm.
What limits itImmediate-release use can provoke reflex tachycardia and ischemia; edema and CYP3A4 interactions remain common problems.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Vasospastic angina; chronic stable angina | Adults | 10 mg TID | 10–20 mg TID | 180 mg/day |
Titration Titrate over 7–14 days (may be faster with frequent assessment; up to 10 mg increments over 4–6 h in hospitalized patients).
Renal Undefined (used safely in renal dysfunction; rare reversible BUN/creatinine elevations in pre-existing insufficiency).
Hepatic Undefined.
A single dose should rarely exceed 30 mg.
Available strengths
Pregnancy Teratogenic/embryotoxic in animals; use only if potential benefit justifies risk.
Lactation Undefined.
| Strength | #/mo | generic $/mo | CostPlus | |
|---|---|---|---|---|
| 10 mg | cap | 90 TID | $23.10 | offered |
| 20 mg | cap | 90 TID | $61.70 | offered |
Other forms: Nifedipine ER (GITS) (PROCARDIA XL)
Generic entry1990
NO BOXED WARNINGS
Principal riskReflex tachycardia and peripheral edema
Legacy pregnancy categoryC
Defining liabilityHypotension and reflex tachycardia; overdose can cause severe vasodilatory shock.
Open Nifedipine in the interactive console ↗
